In 1985, Novo Nordisk introduced the first NovoPen®, revolutionising the modern treatment of diabetes and improving the quality of life for people with diabetes.
NovoPen® 3 has a proven track record as one of the most widely used durable insulin pens in the world. NovoPen® 3 is suited for all types of regimens including intensive therapy, since the different colour versions allow easy differentiation of insulin type.
Try the interactive user guide to see how easy NovoPen® 3 is to use.
NovoPen® 3 is a registered trademark of Novo Nordisk A/S.
APROM ID# 1492. June 2010.